Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",48498,300,1.51 [1.27-1.80],2.614059921016129e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",50260,389,1.00 [0.86-1.16],0.9710813565402814
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",49741,2720,1.26 [1.19-1.33],5.020373844228739e-15
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Candidiasis,50299,837,1.34 [1.21-1.48],3.961486694420684e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,48772,6891,1.21 [1.17-1.25],2.63853330308237e-24
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),48956,6277,1.24 [1.19-1.29],3.2373730793102197e-28
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,49802,2395,1.20 [1.13-1.28],4.530046295599794e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,50116,170,1.05 [0.84-1.32],0.6705986632410988
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,46282,1913,1.38 [1.29-1.48],6.781660270705414e-20
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,44709,2166,1.45 [1.36-1.55],6.208037479329488e-30
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,44452,502,1.60 [1.40-1.83],2.247487133967692e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,35358,3882,1.25 [1.19-1.31],5.26297173005215e-19
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,44156,766,1.44 [1.29-1.61],4.1888947842075605e-11
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,50229,2822,1.19 [1.13-1.26],1.731946027303918e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Mycoses,50450,988,1.35 [1.23-1.49],5.698450400043917e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,48848,1827,1.30 [1.21-1.39],3.3378683282238065e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,50315,2117,1.36 [1.28-1.46],1.2423025247515172e-20
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,47798,391,1.00 [0.86-1.16],0.987397936861049
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,50551,97,1.28 [0.94-1.74],0.1118978795806597
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other septicaemia,50046,1848,1.36 [1.27-1.46],6.373523628712317e-18
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,50097,151,0.95 [0.75-1.20],0.6546211484208735
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other viral diseases,50393,307,1.23 [1.03-1.46],0.021287747139419
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",50358,272,1.15 [0.95-1.38],0.1467391147175755
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,47840,819,1.40 [1.26-1.55],3.4320407892714917e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,47571,550,1.21 [1.07-1.38],0.0032176207147026
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,47625,218,1.43 [1.17-1.76],0.0006226529851007
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,50510,103,1.66 [1.25-2.21],0.0005420631085304
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,50422,293,1.06 [0.89-1.26],0.543896011041594
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral warts,50225,96,0.91 [0.67-1.22],0.5186286197665158
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],50252,123,1.08 [0.82-1.41],0.5968249773701497
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm,49980,580,0.94 [0.83-1.06],0.3110364731951658
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,50380,116,0.98 [0.74-1.29],0.8696090315780424
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,50349,123,0.78 [0.61-1.00],0.0510305624868993
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23268,129,0.82 [0.64-1.05],0.1177783414642435
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",49898,2826,0.99 [0.94-1.05],0.8410128072428847
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of meninges,50524,112,1.07 [0.80-1.42],0.6443711656936691
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,50424,128,1.34 [1.02-1.75],0.0333185074789478
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,50503,206,1.03 [0.84-1.27],0.7824074720261409
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of ovary,27154,174,0.99 [0.79-1.24],0.9087462850793632
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Ascending colon,50506,713,0.96 [0.86-1.07],0.4767049497888282
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Caecum,50506,585,1.02 [0.90-1.15],0.7861419089773831
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",50335,143,0.92 [0.72-1.17],0.4934204836482448
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Descending colon,50502,426,0.99 [0.85-1.14],0.8399071360745564
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Rectum,50425,693,0.95 [0.85-1.07],0.4186435980836239
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,50330,1198,1.06 [0.97-1.16],0.1854116773927841
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Transverse colon,50488,844,1.03 [0.93-1.14],0.6188998125784541
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Carcinoma in situ of breast,22090,138,0.92 [0.72-1.19],0.5414425727133408
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22181,166,0.81 [0.65-1.01],0.0565925981060349
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",40284,100,1.26 [0.92-1.71],0.1440296669960559
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",40319,135,1.18 [0.90-1.53],0.2316081371906965
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",50452,232,1.00 [0.82-1.22],0.9847177290051504
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Haemangioma, any site",50453,227,0.98 [0.81-1.20],0.8670718200320839
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Leiomyoma of uterus,26247,581,0.85 [0.76-0.96],0.0092648204532451
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Lung cancer and mesothelioma,35061,653,1.10 [0.98-1.23],0.1214004707213049
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Lymphoid leukaemia,40283,99,1.35 [0.99-1.84],0.0576454212778617
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",40554,370,0.99 [0.84-1.15],0.868988834350181
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",40581,397,1.15 [0.99-1.34],0.0771489491904133
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22309,181,0.89 [0.72-1.10],0.2953203854043114
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",40341,157,1.46 [1.14-1.86],0.0026436157826201
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",40398,214,1.17 [0.95-1.44],0.1439201420181879
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",40378,194,1.22 [0.98-1.52],0.0739027616927757
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22268,140,0.90 [0.70-1.16],0.4137586948728045
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",40362,178,0.86 [0.70-1.07],0.1814485608068318
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19412,1356,0.99 [0.91-1.07],0.782771029063297
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",40407,223,0.93 [0.77-1.14],0.4971875082746885
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",40330,146,1.00 [0.78-1.28],0.9942436134323948
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,40393,209,1.00 [0.81-1.24],0.9715671397771984
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanocytic naevi,50162,395,0.97 [0.83-1.12],0.6459045758953852
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanocytic naevi of trunk,50469,171,1.05 [0.83-1.32],0.6946057785246614
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanoma in situ,40249,159,0.98 [0.77-1.25],0.8945917915387837
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",40362,178,1.22 [0.97-1.54],0.0887572173789964
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",40496,312,1.38 [1.16-1.64],0.0003080609177845
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",40630,446,0.99 [0.86-1.14],0.8720223467105513
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",40378,194,1.38 [1.11-1.72],0.0044166792535099
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Other benign neoplasms of skin,50195,306,1.19 [1.00-1.41],0.0525427111476735
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",42285,2101,1.07 [1.00-1.14],0.0473420433038619
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",42400,2216,1.07 [1.00-1.14],0.035912721140333
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,49970,674,1.41 [1.26-1.59],4.325393916128103e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,46863,219,1.95 [1.62-2.36],3.5865130027190808e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,49437,141,1.61 [1.26-2.05],0.0001581091828
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,48996,5650,1.24 [1.19-1.29],1.707825389004144e-24
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,47668,96,1.60 [1.19-2.16],0.0018279425928265
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,49741,101,1.78 [1.35-2.36],4.985512088607243e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,49597,2953,1.23 [1.16-1.30],8.642448627568499e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,49595,2951,1.22 [1.16-1.29],1.237484386443459e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,46815,171,1.58 [1.26-1.98],7.911300398537671e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,49908,2336,1.23 [1.15-1.31],1.0866213997058012e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,49856,216,1.34 [1.09-1.64],0.0054456660276529
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,49422,126,1.46 [1.12-1.91],0.005225000603358
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,49412,116,1.20 [0.90-1.59],0.2068457243281815
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,50182,542,1.60 [1.41-1.81],1.845352988513846e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,50346,106,1.71 [1.30-2.25],0.0001484809503284
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",50086,446,1.62 [1.41-1.86],5.7150723182644374e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,47781,209,1.17 [0.95-1.44],0.1414196234754446
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,39128,617,1.47 [1.31-1.66],2.149095946039308e-10
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,47141,228,1.08 [0.89-1.32],0.4342082479738671
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,47159,246,1.37 [1.12-1.66],0.001745602851209
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,38618,107,1.25 [0.93-1.67],0.1340936322090561
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,46941,134,1.05 [0.81-1.36],0.7146763589936078
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,45831,471,1.37 [1.19-1.57],6.972814323742393e-06
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",49621,1115,1.34 [1.22-1.47],2.558879213373161e-10
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,49026,520,1.06 [0.93-1.21],0.4122188065109551
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,48757,251,1.01 [0.84-1.22],0.8981074849651773
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,49849,3042,1.06 [1.00-1.12],0.0403954702941298
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,44020,2948,1.08 [1.02-1.15],0.0048687231528544
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",38639,128,1.36 [1.04-1.77],0.0229508758659115
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",46603,159,1.78 [1.42-2.23],5.243964753105565e-07
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,39062,551,1.36 [1.20-1.55],2.249198337564232e-06
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,38629,118,1.14 [0.86-1.50],0.3664391408204251
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,45414,6903,1.00 [0.97-1.04],0.9890320056557892
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,38895,384,1.30 [1.11-1.51],0.0008811983647614
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,39603,1092,1.30 [1.18-1.42],2.2912873305983043e-08
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,50391,638,1.17 [1.04-1.32],0.0107493039059114
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,50023,270,1.25 [1.04-1.50],0.0172183406842186
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,38760,249,1.35 [1.11-1.63],0.0023452030722087
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",38631,120,1.54 [1.18-2.02],0.0014359562646481
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,49485,3041,1.15 [1.09-1.21],8.292918592904592e-07
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,39016,505,1.69 [1.49-1.92],2.9923466996824862e-16
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,39097,586,1.72 [1.53-1.93],1.0131980787139457e-19
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",39753,1242,1.01 [0.93-1.10],0.8284863746158313
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,38743,232,1.14 [0.93-1.38],0.2030993724203482
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,50006,253,1.25 [1.04-1.51],0.0192315731915449
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,39693,1182,1.36 [1.24-1.48],8.870877550627417e-12
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,39458,947,1.23 [1.11-1.35],3.8222633987957145e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,45500,140,1.41 [1.09-1.81],0.0085224162300615
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,48244,9733,1.07 [1.04-1.11],5.55550989929231e-06
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,46541,97,0.93 [0.69-1.26],0.6588665999700236
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,46554,110,0.92 [0.69-1.21],0.5447907992617623
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,50188,3815,1.05 [1.00-1.10],0.0690338170310815
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",50191,3811,1.04 [1.00-1.10],0.0725293531174609
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,46549,105,1.05 [0.78-1.41],0.755713437824008
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,49873,2374,1.02 [0.96-1.09],0.4949062949432599
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",41609,3098,1.32 [1.25-1.39],4.727669699321665e-24
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,50526,443,1.79 [1.57-2.04],3.671864823820252e-18
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,48668,162,1.33 [1.04-1.68],0.0204960032893757
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,47704,205,0.98 [0.80-1.21],0.8521110262097772
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,47779,280,1.03 [0.86-1.23],0.7723295980820719
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",38844,333,1.19 [1.00-1.40],0.0436535545440118
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,46014,305,1.67 [1.42-1.97],1.234324363895912e-09
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,4131,169,1.58 [1.27-1.96],3.886682351477141e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,4402,494,1.35 [1.18-1.54],1.128123910615766e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,45833,124,2.30 [1.84-2.87],2.58029978789988e-13
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,4070,111,2.17 [1.72-2.75],7.982259303367127e-11
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,49283,3574,1.31 [1.25-1.38],1.1129048312655686e-26
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,49195,689,1.15 [1.03-1.29],0.0158490413452475
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,46083,723,1.18 [1.05-1.32],0.0044042652755557
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,40014,1503,1.27 [1.18-1.38],7.507387216727042e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",50333,477,1.17 [1.02-1.35],0.0243268906682225
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),48342,324,1.20 [1.02-1.41],0.0305514869339636
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Angina pectoris,46160,2342,1.08 [1.01-1.15],0.0160066085894138
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Aortic aneurysm,48493,475,1.21 [1.05-1.39],0.0069029626604112
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,48133,115,1.58 [1.21-2.08],0.0008951494291459
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",48413,395,1.37 [1.18-1.59],4.545437364033191e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,31383,3718,1.23 [1.17-1.29],2.9621772602246197e-16
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,AV-block,42597,841,1.14 [1.03-1.27],0.0128819684077762
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",50435,829,1.00 [0.90-1.11],0.9768047772972568
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Cardiac arrest,28045,380,1.42 [1.22-1.66],5.703806791445085e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Cardiomyopathy,42090,334,1.22 [1.03-1.44],0.0191091725725325
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",41944,188,1.39 [1.11-1.73],0.0033782584532061
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,50547,100,1.10 [0.81-1.48],0.5347918109518744
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Conduction disorders,43814,2058,1.17 [1.09-1.25],4.725261570916499e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,47874,4091,1.09 [1.04-1.14],0.0002319142438454
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,44105,14764,1.10 [1.08-1.13],7.404530601718614e-15
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,DVT of lower extremities,47855,514,1.16 [1.01-1.32],0.0321652955621148
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Endocarditis,41902,146,1.21 [0.94-1.55],0.1347581071656188
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Heart failure, strict",50146,2158,1.31 [1.23-1.40],8.524646300930099e-17
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypertension,45903,12679,1.10 [1.07-1.13],2.505863387034405e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, essential",45940,12716,1.10 [1.07-1.13],1.2111239644983216e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, portal",50221,147,2.69 [2.29-3.15],1.829303712342005e-34
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",33573,349,1.54 [1.32-1.79],3.614941162912056e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,33494,270,1.90 [1.63-2.23],1.2273993976510342e-15
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypotension,50266,2312,1.22 [1.15-1.30],6.084007101100463e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,48739,208,1.13 [0.92-1.39],0.24962158702755
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",48200,4382,1.08 [1.03-1.13],0.0005656143592832
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",49808,1095,1.24 [1.13-1.36],2.7814943594375674e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Left bundle-branch block,42465,709,1.28 [1.14-1.43],1.6652133919981965e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,49611,1641,1.10 [1.03-1.19],0.0082524365197634
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",45199,1381,1.14 [1.05-1.24],0.0013630101608173
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",50364,303,1.04 [0.87-1.23],0.6878841006997274
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",50495,603,1.14 [1.01-1.29],0.0386990898005329
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Oesophageal varices,47443,102,2.60 [2.11-3.21],3.719417321989825e-19
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other aneurysm,48173,155,1.31 [1.03-1.67],0.0295857528959039
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other arrhythmias,42578,822,1.20 [1.08-1.33],0.0006574473642585
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,48214,196,1.43 [1.16-1.77],0.000888001151744
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,48487,469,1.33 [1.16-1.53],5.579246015578973e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,42097,341,1.12 [0.95-1.32],0.1668282929935361
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other disorders of veins,47530,189,1.10 [0.88-1.36],0.4179833651618695
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,47434,93,1.23 [0.90-1.69],0.1948487327923707
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,47747,129,1.03 [0.79-1.34],0.8297048119109539
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,47607,266,1.10 [0.92-1.33],0.3030928869223031
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,43793,2037,1.22 [1.14-1.30],3.782680653389059e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,48059,105,2.67 [2.20-3.24],1.7586256369287206e-23
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,49080,1062,1.26 [1.15-1.38],7.780274448364884e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,49343,684,1.52 [1.36-1.70],3.57084933475438e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",48814,1196,1.19 [1.09-1.30],8.211268986778248e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28324,659,1.26 [1.12-1.42],0.0001108399459536
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Peripheral artery disease,48753,796,1.44 [1.30-1.60],9.33577536177304e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),48012,671,1.20 [1.06-1.35],0.0027163618861141
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Pulmonary embolism,49596,937,1.21 [1.10-1.34],0.0001149926124919
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,50411,1287,1.30 [1.19-1.41],1.0636244812351976e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Right bundle-branch block,42440,684,1.21 [1.08-1.36],0.0012616254446256
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Secondary right heart disease,49333,674,1.52 [1.36-1.71],3.5109822932189483e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,47992,374,1.31 [1.12-1.53],0.0007187448083977
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",49785,1254,1.22 [1.12-1.32],6.125793382811703e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",49746,1329,1.24 [1.14-1.34],4.33752111654606e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,48686,116,1.21 [0.91-1.60],0.1852128153195151
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,48178,161,1.21 [0.96-1.54],0.1108048756337288
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Transient ischemic attack,49174,461,1.03 [0.89-1.18],0.7232872897192657
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,48482,512,1.04 [0.91-1.19],0.5516247438007242
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Varicose veins,48166,825,1.19 [1.07-1.32],0.0015525679241675
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,48047,166,1.24 [0.98-1.56],0.0769538778624936
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Venous thromboembolism,50114,1473,1.20 [1.11-1.30],5.169853936352987e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",50313,703,1.17 [1.05-1.32],0.0057042805413397
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",44231,2806,1.04 [0.99-1.10],0.1401195570385835
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Any mental disorder,49259,7834,1.08 [1.04-1.11],2.069347824583525e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",50222,833,1.13 [1.01-1.25],0.0253329498582839
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",44522,3097,1.08 [1.03-1.14],0.0039977155718837
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",41602,177,1.05 [0.84-1.31],0.6737683289832014
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Smoking dependency,49505,2678,1.16 [1.10-1.23],1.947851447327623e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",44617,3192,1.13 [1.07-1.19],6.356335256799171e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Vascular dementia,49551,252,1.18 [0.97-1.42],0.0912563890429343
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Alzheimer disease,50550,645,1.01 [0.90-1.14],0.8453648822174239
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",34076,116,1.16 [0.87-1.54],0.3117605300905278
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Bell's palsy,47069,159,1.34 [1.05-1.70],0.0166774244350879
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,47871,961,0.96 [0.87-1.05],0.3827681582790916
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Cerebral cysts,49758,450,1.22 [1.06-1.40],0.0067503640296323
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,50392,635,1.32 [1.17-1.49],4.980673946275125e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,49573,98,1.05 [0.78-1.42],0.7512063005319253
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,50517,119,1.33 [1.01-1.75],0.0398689756605942
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",49450,142,1.27 [0.98-1.64],0.0653284427176448
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Epilepsy,47490,555,1.11 [0.97-1.26],0.1195724667819721
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,49600,2665,1.07 [1.01-1.14],0.0153796951654106
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,50465,1180,1.03 [0.95-1.13],0.4828526295303452
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Falls/tendency to fall,49382,5057,1.13 [1.08-1.17],5.048042989387337e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Generalized epilepsy,49809,104,1.03 [0.77-1.38],0.8417323456565151
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Hemiplegia,50252,495,1.38 [1.21-1.58],2.231935808534553e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Hydrocephalus,49428,120,1.11 [0.84-1.46],0.4718665176276306
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,50512,135,1.19 [0.92-1.55],0.1818951087590827
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,47054,144,0.90 [0.71-1.15],0.4208428049333946
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,47065,155,1.16 [0.91-1.48],0.2209489278169344
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Memory loss,49268,217,1.20 [0.98-1.48],0.0794050127470249
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Migraine,47631,696,1.03 [0.92-1.15],0.6148519275489981
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",50410,626,0.99 [0.88-1.11],0.8537981167331785
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Motor neuron disease,34264,268,1.10 [0.92-1.33],0.2916122342966492
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,50223,208,1.09 [0.88-1.34],0.4195085539020919
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",49238,2328,1.01 [0.95-1.07],0.8319078205833046
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Neurological diseases,47635,7366,1.08 [1.04-1.12],1.0981350326935196e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,49867,392,1.24 [1.07-1.45],0.0051951755664983
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",47712,802,0.98 [0.88-1.09],0.6982508877977665
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",50401,578,1.47 [1.30-1.66],9.725040289664536e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,40202,1266,1.12 [1.03-1.22],0.0085699965248954
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,49448,140,1.28 [0.99-1.65],0.0563936636367261
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other disorders of nervous system,49582,274,1.22 [1.01-1.46],0.0347483811782953
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,49607,322,1.23 [1.04-1.46],0.0164904549378793
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other facial nerve disorders,47097,187,1.32 [1.06-1.64],0.013528771263904
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other headache syndromes,47046,111,0.93 [0.71-1.23],0.6222595131577199
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other neurological diseases,50319,1011,1.18 [1.08-1.30],0.0005464705737749
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other sleep disorders,48023,1088,1.09 [1.00-1.20],0.058925001275241
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Parkinson's disease,50504,835,0.99 [0.89-1.10],0.8404082683378016
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,49417,109,0.87 [0.66-1.15],0.3299860483017138
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Restless leg syndrome,50549,152,1.29 [1.01-1.65],0.0419180417286663
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Sleep apnoea,50069,936,1.09 [0.98-1.20],0.1002530246810796
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Small fibre neuropathy,49917,94,1.20 [0.88-1.64],0.2524574482315234
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,50524,322,1.07 [0.91-1.27],0.4102329948311723
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,47009,99,1.11 [0.82-1.50],0.5099506023728486
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,50550,652,1.01 [0.90-1.14],0.8038672074857285
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),49479,245,1.18 [0.98-1.43],0.0873960727689747
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,49430,197,1.05 [0.84-1.29],0.6838960052031796
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,49747,768,0.98 [0.88-1.09],0.718462618618581
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,50209,458,1.70 [1.48-1.94],1.0442992913574472e-14
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,48592,102,0.79 [0.60-1.05],0.1030073503258023
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,48606,116,1.30 [0.98-1.72],0.0641380283951469
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",50338,104,1.30 [0.97-1.74],0.0836280819348094
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,50036,284,1.00 [0.84-1.20],0.98247942541024
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4080,118,2.08 [1.65-2.62],5.372408427676285e-10
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4953,198,1.48 [1.21-1.82],0.0001428742569826
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,49414,181,1.09 [0.87-1.36],0.4681064261115143
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,50129,2027,1.16 [1.08-1.24],1.9285041385940582e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",49838,1348,1.03 [0.95-1.12],0.4987838349327144
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,48929,439,1.00 [0.87-1.16],0.9663279720163158
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",50386,1407,0.99 [0.91-1.07],0.7667093167142478
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,50530,134,0.95 [0.73-1.22],0.6657142409351009
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,50239,1260,0.99 [0.91-1.08],0.8192258217042016
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",50465,713,1.04 [0.93-1.17],0.4521568200196194
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,50370,349,0.97 [0.83-1.14],0.7110475082922818
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,48609,119,1.09 [0.83-1.43],0.552735672291881
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,48618,128,1.07 [0.82-1.39],0.6204290639111938
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,48598,108,0.86 [0.65-1.13],0.2767819274335719
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,50373,1384,0.98 [0.91-1.07],0.6864979187342657
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,49348,359,1.07 [0.92-1.26],0.3763572734544013
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,49076,97,1.03 [0.76-1.40],0.8517273548261933
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,49949,197,1.06 [0.86-1.31],0.5817246754799882
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,50281,529,1.02 [0.90-1.16],0.7516347331481202
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,49353,374,1.03 [0.88-1.20],0.7167188057460311
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,50236,215,0.97 [0.79-1.19],0.7828897437158854
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,49916,927,1.03 [0.93-1.13],0.5757455576489764
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,49511,278,1.02 [0.86-1.22],0.7927881664665862
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,47424,4234,1.07 [1.02-1.12],0.0058671777832287
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,50212,460,1.06 [0.92-1.21],0.4485026327207566
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,50511,295,1.20 [1.01-1.43],0.0406464629521222
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,49277,787,0.95 [0.86-1.06],0.3456247244771494
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,49880,128,0.91 [0.71-1.18],0.4918584466089436
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,50504,108,0.97 [0.73-1.28],0.8174156091065161
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,48654,164,0.92 [0.74-1.16],0.4927282038234581
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,48773,283,0.93 [0.78-1.11],0.4132867628990887
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,48333,231,1.15 [0.95-1.41],0.1556064820409623
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,49102,123,1.06 [0.81-1.39],0.684845277418506
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",48223,121,1.23 [0.93-1.62],0.1490071593676127
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,49160,171,0.83 [0.67-1.04],0.1005215200617088
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",49365,376,0.94 [0.81-1.09],0.4263522850787645
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,48735,245,0.91 [0.76-1.10],0.3491846482204647
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,48320,218,0.91 [0.75-1.11],0.365079974439811
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,48267,165,1.09 [0.86-1.37],0.4876267824431285
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,46714,3524,1.03 [0.98-1.09],0.1957973194940382
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,48632,142,0.99 [0.77-1.27],0.9496655732102496
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,50048,815,1.07 [0.96-1.19],0.2135158477340315
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,49349,116,1.31 [0.99-1.73],0.0613093528473848
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),49560,327,1.44 [1.22-1.70],1.555703721012711e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,50139,166,1.05 [0.83-1.33],0.6745007358354704
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,50461,236,1.06 [0.87-1.28],0.5837193252977977
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,50299,248,1.04 [0.86-1.26],0.6678194741762178
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,50091,118,1.30 [0.98-1.72],0.0660971403884741
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,50091,118,0.87 [0.67-1.14],0.3134545587251889
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,50357,1747,1.13 [1.05-1.21],0.0012736174462789
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,49863,1253,1.13 [1.04-1.23],0.0052733013127559
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,48856,246,1.05 [0.87-1.27],0.6108254911529227
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,48777,167,1.26 [1.00-1.60],0.0494071478468898
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Acute pharyngitis,50070,149,1.31 [1.02-1.67],0.0347978239283089
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,50340,419,1.38 [1.19-1.59],1.9091018171465303e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,50047,126,1.55 [1.19-2.01],0.0010214868799413
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,All influenza,46602,230,1.76 [1.45-2.12],5.015548477895761e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),46597,225,1.80 [1.49-2.18],1.150606733013041e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Allergic asthma (mode),34632,224,0.94 [0.77-1.15],0.5535022022894531
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Allergic rhinitis,50292,546,0.99 [0.87-1.12],0.8534196435566328
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",37325,3445,1.11 [1.05-1.17],0.0001119945016339
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",37802,3394,1.11 [1.06-1.17],6.584419566259026e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),49754,269,1.34 [1.12-1.61],0.0015864588817303
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",46532,160,1.19 [0.94-1.52],0.1462638694813112
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Bronchiectasis,43842,690,1.26 [1.12-1.41],7.677750447149656e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",43264,112,1.17 [0.88-1.56],0.2738931597598943
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,48579,5427,1.14 [1.09-1.19],3.2376698115653446e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",47856,140,1.03 [0.80-1.32],0.8324642851110056
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Chronic sinusitis,48017,301,0.94 [0.79-1.11],0.4510319452492036
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",50155,2325,1.23 [1.16-1.31],4.5096518684729866e-11
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Deviated nasal septum,47926,210,0.89 [0.72-1.08],0.2356840880730773
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,46503,10284,1.14 [1.11-1.18],1.4947168290217638e-18
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",48431,715,1.06 [0.95-1.18],0.3281715698732211
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Early onset COPD,48445,615,1.26 [1.12-1.43],0.0001952187773773
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Emphysema,43761,609,1.38 [1.23-1.56],9.586784509379389e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,48027,561,1.66 [1.47-1.88],2.0531003611788872e-16
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Influenza and pneumonia,50110,3738,1.29 [1.23-1.36],1.1457443871150101e-24
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Interstitial lung disease,48093,627,1.66 [1.48-1.86],8.493522056565179e-18
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Later onset COPD,48595,1710,1.22 [1.14-1.31],4.9993764849899553e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,50525,654,1.28 [1.14-1.44],4.0530386011420365e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Nasal polyp,47924,208,0.89 [0.72-1.08],0.2360787687968191
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,50060,1899,1.31 [1.22-1.40],1.4746969116564722e-14
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other diseases of pleura,50086,3881,1.25 [1.19-1.32],6.338231482396745e-20
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,49347,1631,0.99 [0.92-1.07],0.838949024886577
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other pleural conditions,46304,99,1.14 [0.84-1.54],0.4125927745714979
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,50377,782,1.61 [1.45-1.79],2.046298440623052e-19
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,50341,2540,1.28 [1.20-1.35],1.0863798357169905e-15
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pleural effusion,48143,1938,1.25 [1.17-1.34],1.0056973944263896e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pleural plaque,46505,300,1.27 [1.07-1.52],0.0071590681295584
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",49621,3249,1.32 [1.25-1.39],1.5875566163766263e-24
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,50394,523,1.28 [1.12-1.46],0.0002250396874712
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pneumothorax,46433,228,1.11 [0.91-1.36],0.2956968801470979
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pollen allergy,50505,464,0.97 [0.85-1.12],0.6957550813951279
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pulmonary oedema,49724,129,1.75 [1.37-2.25],9.602322249880718e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Respiratory insufficiency,34514,106,1.61 [1.21-2.15],0.0010750866322053
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,50022,1861,1.33 [1.24-1.43],1.0963850283541693e-15
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,48264,548,0.99 [0.87-1.13],0.8901287902422443
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Viral pneumonia,46865,493,1.22 [1.06-1.39],0.0052482048228348
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",49783,406,1.24 [1.07-1.44],0.0044527087788822
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23315,219,1.15 [0.94-1.41],0.1727097216938577
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,35731,123,1.16 [0.88-1.52],0.2916448064009374
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute appendicitis,50230,285,0.86 [0.73-1.02],0.0908542983362675
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute gastritis,38041,175,1.20 [0.95-1.51],0.1194785515045041
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute pancreatitis,46954,364,1.22 [1.04-1.43],0.0126425410053679
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute peritonitis,49629,182,1.42 [1.13-1.77],0.0020620851856421
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Alcoholic liver disease,48809,141,2.27 [1.88-2.75],2.330591201467679e-17
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Barrett oesophagus,38722,856,1.09 [0.99-1.21],0.09113584046165
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",46787,197,1.06 [0.86-1.32],0.5677426230488595
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",49725,197,1.05 [0.85-1.30],0.650122661680274
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Cholecystitis,46989,399,1.17 [1.00-1.36],0.047354650277239
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Cholelithiasis,48528,1938,1.23 [1.15-1.32],3.7227265886968302e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Chronic gastritis,38465,599,1.17 [1.04-1.33],0.0111586765606061
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Chronic pancreatitis,46690,100,1.35 [1.00-1.83],0.0475279606421918
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",50272,198,2.46 [2.10-2.88],5.71334411509371e-29
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Coeliac disease,47399,243,1.76 [1.47-2.11],1.0102021437321003e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Collagenous colitis,47278,160,0.86 [0.69-1.09],0.213400118439055
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,50248,361,1.16 [0.99-1.36],0.0660708112182239
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Constipation,50048,3262,1.15 [1.09-1.21],2.636405008915067e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Crohn disease,47301,183,1.67 [1.35-2.07],2.656350679679488e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",49856,135,1.66 [1.30-2.12],5.896101839250333e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Crohn's disease NAS,47292,174,1.79 [1.45-2.21],7.14817839986384e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Dental caries,49099,452,1.19 [1.03-1.37],0.0156953932995505
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,45360,4372,1.02 [0.98-1.07],0.3848320883850006
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of appendix,50304,359,0.85 [0.73-1.00],0.0441825919098264
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of liver,50315,1647,1.40 [1.30-1.50],6.764481527834835e-19
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",46310,8444,1.07 [1.04-1.11],2.944340203220928e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",49740,1093,1.15 [1.05-1.26],0.002796755566409
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of peritoneum,50380,933,1.20 [1.09-1.32],0.0003236431234329
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,48878,231,1.22 [1.00-1.49],0.0463265531396347
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of salivary glands,48580,128,1.15 [0.88-1.50],0.312476055564388
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of the digestive system,49942,2786,1.16 [1.10-1.23],2.380191122040835e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of tongue,48611,216,1.27 [1.03-1.56],0.0235627740213412
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",49329,2739,1.21 [1.14-1.28],8.835756827798573e-11
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,41754,6146,1.05 [1.01-1.09],0.0075735401043602
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Duodenal ulcer,38262,396,1.13 [0.98-1.32],0.1011906269179513
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",50385,319,1.09 [0.92-1.29],0.3073453507683751
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,50376,108,1.34 [1.01-1.79],0.0455561648199386
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,48911,243,2.30 [1.98-2.67],5.467919915797506e-28
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,35893,285,1.13 [0.95-1.36],0.1734185648963474
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Functional dyspepsia,38941,1075,1.08 [0.98-1.18],0.1208500667005186
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastric ulcer,38568,702,1.20 [1.07-1.34],0.0020390978158055
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,42750,4884,1.05 [1.01-1.10],0.022430809410954
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,38916,1050,1.15 [1.05-1.27],0.0024825672779318
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,39135,16206,1.08 [1.06-1.11],1.203716738314752e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,GI-bleeding,49439,2283,1.12 [1.05-1.20],0.0003258608573251
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,48752,105,1.17 [0.87-1.57],0.3111830189746485
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,37518,2464,1.03 [0.97-1.09],0.3446542373052004
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",48793,125,2.16 [1.74-2.69],4.701054863061112e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Hernia,47363,6375,1.02 [0.99-1.06],0.2043130585619547
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Impacted teeth,50390,100,1.35 [1.00-1.82],0.0482877609863154
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Impaction of intestines,35718,110,1.28 [0.96-1.71],0.0916812993340396
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Inguinal hernia,42763,1775,0.99 [0.92-1.06],0.7359165450142376
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",41189,201,0.87 [0.71-1.07],0.1942862578189854
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,35798,190,1.68 [1.37-2.07],9.01414036376349e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Intestinal malabsorption,47438,282,1.70 [1.43-2.02],1.126145628505417e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,36687,1079,1.09 [0.99-1.19],0.076640438821772
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,50494,726,1.34 [1.20-1.49],3.072068503825543e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,48586,1468,1.23 [1.13-1.33],4.105688555356049e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,49070,1952,1.20 [1.12-1.28],2.315911624692184e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oesophageal obstruction,38239,373,1.09 [0.93-1.27],0.2908331885681177
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oesophagitis,39046,1180,1.14 [1.05-1.25],0.002643113352549
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,50454,268,0.99 [0.83-1.19],0.9564223749533198
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,41122,134,1.03 [0.80-1.34],0.8039778226144925
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,38264,2656,1.07 [1.01-1.13],0.0221873167568542
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,47146,556,1.08 [0.95-1.23],0.2163926046536436
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,46894,304,1.17 [0.99-1.40],0.0697632493585623
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of intestine,39021,3413,1.07 [1.01-1.12],0.0131448454079658
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of intestines,46607,10999,1.07 [1.04-1.11],1.025621214381146e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,48567,406,1.03 [0.89-1.20],0.6921643142751701
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of liver,50016,1348,1.42 [1.31-1.54],3.5727161387085065e-17
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,39170,1304,1.08 [0.99-1.17],0.0690449159985572
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of pancreas,46885,295,1.41 [1.19-1.68],0.0001021908836875
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,50247,800,1.16 [1.04-1.29],0.0069187569763565
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,39723,1857,1.16 [1.08-1.24],3.7011744756130215e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,49470,2314,1.12 [1.05-1.19],0.0004402855653264
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,49014,367,1.12 [0.96-1.31],0.1523714309460679
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,38960,3352,1.17 [1.11-1.23],4.444106925248915e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),41804,3938,1.11 [1.06-1.16],2.9772474403950228e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,48858,190,1.55 [1.26-1.92],4.432286948322895e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,48833,1715,1.19 [1.11-1.28],2.924832120832176e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",36279,671,1.26 [1.12-1.41],0.000130947575811
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,50356,126,1.23 [0.94-1.61],0.1352295746247147
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,36569,961,1.29 [1.17-1.42],3.4685694337546445e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",47446,290,1.17 [0.98-1.40],0.0804008570680464
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Recurring oral aphthae,50529,108,1.29 [0.97-1.73],0.0848434128660941
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,48658,228,1.52 [1.25-1.85],2.552972578068015e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Toxic colitis,47229,111,1.40 [1.05-1.86],0.022934262428425
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,38391,525,1.09 [0.95-1.24],0.2204803043441689
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ulcerative colitis,47429,311,1.32 [1.11-1.56],0.001665265703436
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",47378,260,1.36 [1.13-1.64],0.0013312792423467
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Umbilical hernia,41522,534,1.12 [0.98-1.27],0.0984151332146263
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,35948,340,1.20 [1.02-1.42],0.027712074762987
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ventral hernia,41502,514,1.26 [1.10-1.44],0.0008071063686046
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Volvulus,35769,161,1.10 [0.87-1.40],0.4143082496817771
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,50386,579,1.07 [0.95-1.22],0.2633989267543261
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,49918,142,1.18 [0.92-1.53],0.1909108480374893
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,46520,317,1.11 [0.93-1.31],0.240840649807184
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,49297,1351,1.26 [1.16-1.37],3.1550523717064343e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",48286,340,1.20 [1.02-1.41],0.0313269238478075
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,47005,802,1.35 [1.22-1.51],1.8490737824838443e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,49956,550,1.23 [1.08-1.40],0.0019038516076048
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,50355,949,1.26 [1.14-1.39],3.07263828890337e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,49498,92,1.75 [1.31-2.33],0.0001409861821032
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,47501,6270,1.16 [1.11-1.20],7.791722599553284e-14
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,49665,874,1.00 [0.91-1.11],0.9419366808824532
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,49408,617,1.00 [0.88-1.12],0.9472802206539972
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,49778,1832,1.22 [1.13-1.31],5.0974864723986775e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",50518,106,0.75 [0.58-0.97],0.0273204015454467
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,46315,112,1.23 [0.92-1.63],0.1625342928876247
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,48895,104,1.20 [0.90-1.61],0.2165812888113815
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,49935,529,1.23 [1.08-1.41],0.0018870619751562
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,47095,892,1.16 [1.05-1.28],0.0048162098519413
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,46330,127,1.17 [0.90-1.53],0.2495522988216947
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,50379,164,1.09 [0.87-1.38],0.4554272098552241
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,48315,369,1.29 [1.11-1.51],0.0012564124670473
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,50154,378,1.07 [0.91-1.25],0.4075207419228621
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,49534,128,1.17 [0.90-1.53],0.2467886265207527
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,46337,134,0.99 [0.77-1.28],0.9560582472247274
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,49415,3212,1.18 [1.12-1.24],1.0581915619795631e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",47170,967,1.17 [1.06-1.29],0.0016303301388446
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,46337,134,1.18 [0.91-1.53],0.21570853197613
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,50377,601,1.01 [0.90-1.14],0.8480298919083129
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,49541,135,1.47 [1.14-1.90],0.0029138838094487
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,50269,493,1.08 [0.94-1.24],0.2676675118393099
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,50442,635,1.10 [0.98-1.24],0.1133328343072998
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,46454,251,1.17 [0.97-1.42],0.1068034605676264
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,46734,531,1.06 [0.93-1.20],0.4216705678374091
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,50420,613,1.11 [0.98-1.25],0.0981884355109964
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",46668,465,1.52 [1.33-1.74],7.36233924406377e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,50492,277,1.29 [1.08-1.55],0.0053765627167509
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,43361,212,1.04 [0.84-1.28],0.7234068303762877
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,46005,11006,1.06 [1.03-1.09],3.177765392016741e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,43234,8235,1.05 [1.02-1.09],0.0028005129710355
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,43294,145,0.94 [0.73-1.20],0.5952419877560536
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,43823,300,1.02 [0.86-1.21],0.8423332778445121
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,43878,355,1.16 [0.99-1.37],0.0623699123180172
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,50062,182,0.98 [0.78-1.21],0.8229426915995892
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",43720,197,1.49 [1.20-1.84],0.0002435355682403
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,37212,2213,1.04 [0.98-1.11],0.1890117078090645
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",50284,364,1.01 [0.86-1.18],0.905631201336048
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,44388,865,1.06 [0.95-1.17],0.3016578801165336
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,42721,14170,1.06 [1.03-1.09],4.380692184716002e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,46690,231,1.23 [1.01-1.50],0.0434205944930445
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,43448,299,1.26 [1.06-1.50],0.0092227669649399
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,44259,1110,0.99 [0.91-1.08],0.8329637379978692
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,48736,5213,1.07 [1.03-1.12],0.000932483856282
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,43678,529,1.09 [0.96-1.25],0.1737442766556052
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,43588,439,0.97 [0.84-1.11],0.6268712975062176
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,43415,266,1.01 [0.84-1.21],0.9454841054415072
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,49299,134,1.01 [0.78-1.31],0.9412800799800096
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,38294,3295,1.02 [0.97-1.08],0.4329602559160868
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,36184,1185,1.21 [1.11-1.32],2.8020803893352e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",50401,1169,1.19 [1.09-1.30],8.820656748245392e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,35145,146,0.66 [0.54-0.81],8.573538577726708e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),35643,644,1.04 [0.93-1.18],0.4770235271364277
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,43746,597,0.99 [0.88-1.12],0.9088598075877832
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,36245,1246,0.96 [0.88-1.04],0.3166231574525571
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,43630,107,1.42 [1.06-1.90],0.0178863323333194
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,44755,1232,1.03 [0.95-1.12],0.4936038008006298
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,44114,591,0.98 [0.87-1.11],0.8003610407575984
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,36163,1164,0.96 [0.88-1.05],0.3496755553163514
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,43303,154,1.31 [1.03-1.67],0.0307996133846898
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",43270,121,1.22 [0.93-1.61],0.1571844526364901
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,46600,141,1.53 [1.19-1.96],0.0008278535240949
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,49787,3328,1.16 [1.10-1.22],3.351768143067696e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,48636,2177,1.18 [1.10-1.26],1.3821105153021898e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",50268,878,1.29 [1.17-1.43],8.768081549826415e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,39848,4849,1.10 [1.05-1.15],3.533140042601159e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,35121,122,1.11 [0.85-1.47],0.4375095955180215
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,43332,183,0.99 [0.80-1.24],0.9459612707651696
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,35091,92,1.48 [1.08-2.03],0.0154791354403572
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),35242,243,0.99 [0.81-1.20],0.9007427431185776
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,46933,474,1.08 [0.94-1.24],0.2866774400169529
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,47195,736,1.14 [1.02-1.27],0.0264792581579217
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,50485,194,1.21 [0.98-1.51],0.0808996823544234
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",47053,3530,1.04 [0.99-1.10],0.0905728916032758
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,43342,193,1.03 [0.83-1.28],0.7640829449160811
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),35270,271,1.15 [0.96-1.39],0.1357129823920019
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,44928,1405,0.99 [0.91-1.07],0.7564703615020131
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,39213,4214,1.07 [1.02-1.12],0.0052347280799454
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,49347,182,1.09 [0.87-1.37],0.4373745204358724
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,50512,136,1.23 [0.95-1.59],0.1220141657800018
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,43312,163,1.09 [0.86-1.38],0.486643076318219
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",45588,2439,1.15 [1.08-1.22],5.8334260993902686e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,43325,176,1.25 [0.99-1.57],0.0575336289734908
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,38156,3157,1.05 [1.00-1.11],0.0709300337980037
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,46679,220,0.89 [0.73-1.08],0.2362461794684603
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,43253,104,1.28 [0.95-1.72],0.1040962829404138
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,43832,309,1.05 [0.88-1.24],0.6099268799275072
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,44226,1077,1.23 [1.12-1.35],1.044759647875878e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,49857,692,1.22 [1.09-1.37],0.0007007950699001
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,44643,1120,1.11 [1.01-1.21],0.0233214445896781
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,50292,854,1.31 [1.18-1.45],2.7689146931029185e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,50506,104,1.69 [1.28-2.24],0.0002313529623807
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,43520,371,0.96 [0.82-1.12],0.5985940026794409
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,40007,1478,1.16 [1.07-1.25],0.0002747160243149
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,44285,1136,1.12 [1.02-1.22],0.012722284705095
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],43591,442,1.11 [0.96-1.28],0.1477899527030006
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",35107,108,1.30 [0.97-1.75],0.0816022804565643
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,39848,4849,1.10 [1.06-1.15],8.454418743520069e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,36279,1280,1.08 [0.99-1.18],0.0654606470961334
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,49626,461,1.13 [0.98-1.30],0.1027078900867824
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",50419,128,1.10 [0.84-1.44],0.4710516924530133
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",46315,97,0.89 [0.68-1.16],0.3882251008587127
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,35137,138,1.25 [0.96-1.62],0.0908856356489925
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,43716,193,1.11 [0.89-1.37],0.3661299880604997
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,35888,889,1.31 [1.18-1.45],3.121518678823015e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,43751,602,1.02 [0.90-1.15],0.7735960907415875
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,44019,496,0.92 [0.81-1.05],0.2431746778511285
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,43891,368,1.11 [0.95-1.30],0.1864435487196445
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,39560,114,1.07 [0.81-1.42],0.6351105978912903
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",50514,112,1.65 [1.26-2.17],0.0003314212759858
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,44303,1154,1.03 [0.94-1.12],0.5758491539067405
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],49339,174,1.62 [1.29-2.02],2.544879057345795e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,48176,5027,1.08 [1.04-1.13],0.000235133592192
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",43406,257,1.25 [1.03-1.51],0.0217027488376242
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,44589,1066,1.14 [1.04-1.25],0.0067393075549362
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,47800,454,1.08 [0.94-1.24],0.2929838563763049
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,43923,400,0.90 [0.78-1.04],0.1675105564026731
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,46570,3047,1.10 [1.04-1.16],0.0006967245858443
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,45530,2007,1.08 [1.01-1.16],0.020932009644104
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],43256,107,0.85 [0.65-1.12],0.2479585405794589
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,49420,255,1.61 [1.34-1.94],3.1858919697377935e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,43469,320,0.93 [0.79-1.10],0.4108646645385214
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,43299,150,1.35 [1.05-1.73],0.0186118684936488
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),35112,113,1.37 [1.03-1.82],0.0326553675482288
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Acute renal failure,48501,3085,1.48 [1.40-1.56],5.201424882869715e-46
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20386,101,1.12 [0.83-1.51],0.4599298284379751
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26533,111,0.95 [0.72-1.26],0.7272942840971843
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,49917,622,1.08 [0.96-1.22],0.2011892208106835
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,49462,167,1.10 [0.87-1.39],0.4091372021610061
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,48413,2997,1.47 [1.39-1.55],1.5601210522003762e-42
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,50121,159,1.78 [1.43-2.21],2.2569175976592018e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,50064,593,1.17 [1.04-1.33],0.0106956952667554
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Cystitis,44513,454,1.09 [0.95-1.26],0.2124470025121453
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Dialysis,45576,160,2.41 [1.99-2.91],7.895559952948187e-20
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22062,3247,0.99 [0.94-1.04],0.5951196564659889
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26762,340,1.05 [0.89-1.23],0.5775397034105616
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Endometriosis,20462,177,0.99 [0.79-1.23],0.8967210234124524
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",20682,397,0.90 [0.78-1.05],0.1888303650637198
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21287,1002,1.05 [0.95-1.15],0.3298481126028395
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,42182,10482,1.11 [1.08-1.14],2.530031162688863e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,50127,165,2.08 [1.70-2.53],5.125496269922507e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Hydrocele,19023,208,0.93 [0.76-1.14],0.4816044570007324
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,45397,571,1.14 [1.00-1.30],0.0426547186725022
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21360,2545,1.01 [0.95-1.07],0.7171665876741997
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26693,393,1.00 [0.86-1.16],0.9616103055797558
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19045,230,0.84 [0.70-1.01],0.0704854134285662
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Irregular menses,26772,130,0.98 [0.75-1.28],0.8891944224406605
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Menorrhagia,20590,305,0.91 [0.77-1.08],0.2648672963019997
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,44216,157,1.19 [0.93-1.51],0.1581283196014885
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,22718,2433,1.02 [0.96-1.09],0.4658595694301762
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,18924,109,0.89 [0.68-1.18],0.4164854912460674
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20426,141,1.09 [0.85-1.41],0.489873732534369
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",50524,122,1.02 [0.78-1.33],0.9098756804348854
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",50531,129,1.16 [0.89-1.52],0.260165561574905
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,48488,4429,1.11 [1.06-1.16],1.2971671161425629e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,45460,1401,1.01 [0.93-1.09],0.8799948496224624
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26542,120,1.06 [0.80-1.39],0.6951259053911922
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,50412,941,1.27 [1.15-1.40],1.8271101358625244e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19123,308,1.04 [0.88-1.23],0.6380314679119293
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19095,280,0.93 [0.78-1.11],0.4374709046073868
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19035,220,0.89 [0.74-1.08],0.2529427691940181
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,50471,140,0.98 [0.76-1.25],0.8466647715339846
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,47480,3421,1.17 [1.11-1.23],2.08873382738006e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26501,201,0.95 [0.77-1.17],0.6224673972346992
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20436,151,0.99 [0.78-1.26],0.9302637737281868
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20652,367,1.00 [0.85-1.16],0.9523288152581816
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20394,109,1.21 [0.90-1.62],0.2010545281152077
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20489,204,0.92 [0.75-1.13],0.4471652462480272
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,45494,668,1.12 [0.99-1.25],0.0694583860960104
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,49785,314,1.28 [1.08-1.51],0.0047486323134125
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20590,305,1.00 [0.84-1.18],0.969420130931448
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20392,107,0.75 [0.58-0.98],0.0364129962478034
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,20922,637,0.97 [0.86-1.09],0.6192824800294958
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20443,158,1.08 [0.85-1.38],0.5150794360813635
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,20867,582,1.06 [0.94-1.21],0.3248970898693546
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,50059,97,1.46 [1.07-1.98],0.0155159128455328
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19078,263,1.00 [0.83-1.19],0.9601581120779712
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,50052,5226,1.33 [1.28-1.39],4.3100036195792714e-41
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",45064,238,1.30 [1.07-1.59],0.009653135085739
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,45674,258,1.82 [1.53-2.18],4.72309151613222e-11
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,49407,112,1.26 [0.95-1.68],0.1055391802100161
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Urethral stricture,44486,427,1.09 [0.94-1.26],0.2361183933451473
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Urolithiasis,50070,775,1.10 [0.98-1.22],0.0965334050129514
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20427,142,0.92 [0.72-1.18],0.520021233270495
